Carlton James Newsfeed
  • Loading stock data...

Category: N2:IPO

GIC-backed clinical trial firm WCG eyes up to $6.45 billion valuation in U.S. IPO

(Reuters) – WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, said on Tuesday it was aiming to raise up to $765 million in its U.S. initial public offering. The IPO...

Read More

Cash-hungry emerging markets arrive late to the SPAC party

By Tom Arnold LONDON (Reuters) -Emerging markets have so far been on the fringes of a fundraising...

Read More